Et avec le gnrique, le cot dun traitement mensuel nest plus que de 149$
UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
Annals of the New York Academy of Sciences, 1033(1), 3041
Unexpected changes in appetite, blood sugar levels, or weight after a missed dose may indicate individual sensitivity to treatment interruptions, particularly for patients with type 2 diabetes or prediabetes
Most patients notice reduced appetite within the first few weeks
They are not intended for human consumption, veterinary use, or clinical application